(ORCX) Defiance Daily Target 2X - Overview

ETF Category: Trading--Leveraged Equity | Exchange: NASDAQ (USA) | Market Cap: 366m USD | Total Return: -2% in 12m

Leveraged Swaps, Options Contracts
Total Rating 29
Safety 55
Buy Signal 0.44
Trading--Leveraged Equity
Category Rotation: -5.2
AUM: 366M
Avg Turnover: 67.6M
Risk 3d forecast
Volatility129%
VaR 5th Pctl21.8%
VaR vs Median-5.99%
Reward TTM
Sharpe Ratio0.50
Rel. Str. IBD65.8
Rel. Str. Peer Group35.4
Character TTM
Beta4.000
Beta Downside4.000
Hurst Exponent0.428
Drawdowns 3y
Max DD85.98%
CAGR/Max DD-0.20
CAGR/Mean DD-0.40

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: ORCX Defiance Daily Target 2X

The Defiance Daily Target 2X Long ORCL ETF (ORCX) is an actively managed, non-diversified fund designed to provide 200% of the daily price performance of Oracle Corporation. To achieve this leverage, the fund utilizes financial derivatives including swap agreements and listed options contracts.

Oracle operates within the enterprise software sector, primarily generating revenue through cloud services, license support, and hardware systems. The business model has shifted significantly toward a high-margin Software-as-a-Service (SaaS) and Infrastructure-as-a-Service (IaaS) framework to compete in the global cloud computing market.

As a leveraged instrument, ORCX is intended for short-term trading rather than long-term investment due to the effects of daily compounding and volatility decay. Investors should examine the underlying equity metrics on ValueRay to better understand the risks associated with leveraged exposure.

Headlines to Watch Out For
  • Cloud infrastructure revenue growth accelerates via OCI and AI demand
  • Oracle Database 23ai adoption drives high-margin software licensing
  • Strategic cloud partnerships with Microsoft, Google, and AWS expand reach
  • Capital expenditures rise to support massive data center expansion plans
What is the price of ORCX shares?

As of May 29, 2026, the stock is trading at USD 48.05 with a total of 2,386,914 shares traded.
Over the past week, the price has changed by +16.60%, over one month by +45.92%, over three months by +78.36% and over the past year by -2.04%.

Is ORCX a buy, sell or hold?

Defiance Daily Target 2X has no consensus analysts rating.